Results 81 to 90 of about 4,260 (116)

Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1. [PDF]

Front Pharmacol, 2023
Chen Y, Liu J, Chen Y, Zhang R, Tao J, Chen X, Wang H, Sun Q, Wu J, Liu S.   +9 more
europepmc   +1 more source

Physiological significance of antithrombin D-helix interaction with vascular GAGs. [PDF]

Blood Adv
Biswas I, Panicker SR, Lupu F, Rezaie AR.   +3 more
europepmc   +1 more source

Synthesis and characterization of ternary chitosan-TiO₂-ZnO over graphene for photocatalytic degradation of tetracycline from pharmaceutical wastewater. [PDF]

Sci Rep, 2021
Asadzadeh Patehkhor H, Fattahi M, Khosravi-Nikou M.   +2 more
europepmc   +1 more source

A non-genotoxic stem cell therapy boosts lymphopoiesis and averts age-related blood diseases in mice. [PDF]

Nat Commun
Konturek-Ciesla A, Zhang Q, Kharazi S, Bryder D.   +3 more
europepmc   +1 more source

Combined HRAS and NRAS ablation induces a RASopathy phenotype in mice. [PDF]

Cell Commun Signal
Fuentes-Mateos R, García-Navas R, Fernández-Infante C, Hernández-Cano L, Calzada-Nieto N, Juan AO, Guerrero C, Santos E, Fernández-Medarde A.   +8 more
europepmc   +1 more source

Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity. [PDF]

Mol Ther
Thomas R, Ritchey JK, DiPersio JF, Kim MY.   +3 more
europepmc   +1 more source

Age-associated imbalance in immune cell regeneration varies across individuals and arises from a distinct subset of stem cells. [PDF]

Cell Mol Immunol
Nogalska A, Eerdeng J, Akre S, Vergel-Rodriguez M, Lee Y, Bramlett C, Chowdhury AY, Wang B, Cess CG, Finley SD, Lu R.   +10 more
europepmc   +1 more source

From post-war reconstruction to the twenty-first century - ophthalmic pathology in Freiburg 1945-2015: review of 39,256 surgical specimens from various topographical regions collected over 71 years at a large German tertiary eye care centre. [PDF]

BMC Ophthalmol
Glegola M, Schulz T, Nuessle S, Boehringer D, Stifter J, Englbrecht T, Reinhard T, Haedrich J, Auw-Haedrich C.   +8 more
europepmc   +1 more source

Natural killer cells act as an extrinsic barrier for in vivo reprogramming.

Development, 2022
Melendez E, Chondronasiou D, Chondronasiou D, Mosteiro L, Martínez de Villarreal J, Fernández-Alfara M, Lynch CJ, Grimm D, Real FX, Alcamí J, Climent N, Pietrocola F, Serrano M.   +12 more
europepmc   +1 more source

Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond. [PDF]

Ther Adv Med Oncol
Yamamoto K, Nakayama I, Shitara K.
europepmc   +1 more source